Stem Cell Media, LLC.

InvestorStemCell.com is dedicated to bringing investors and stakeholders together in thoughtful discussion to educate and publicize the incredible advancements in the regenerative medicine sector. To find out more about the publicly traded regenerative medicine companies please visit http://investorstemcell.com/   InvestorStemCell.com is currently following the below companies.
Advanced Cell Technology (OTC:ACTC), Geron Corp. (NASDAQ:GERN), BioTime Inc. (AMEX:BTX),Aastrom Biosciences Inc. (NASDAQ:ASTM), Athersys Inc. (NASDAQ:ATHX), International Stem Cell Corp. (OTC:ISCO), MultiCell Technologies, Inc. (OTC:MCET), StemCells, Inc. (NASDAQ:STEM), ThermoGenesis Corp. (NASDAQ:KOOL), Neostem Inc. (AMEX:NBS), RTI Biologics Inc. (NASDAQ:RTIX), Pluristem Therapeutics Inc. (NASDAQ:PSTI) Bio-Matrix Scientific Group, Inc. (PINK:BMSN), Neostem Inc. (AMEX:NBS) Opexa Therapeutics Inc. (NASDAQ:OPXA), STEM CELL AUTHORITY Ltd. (PINK:SCAL), Brainstorm Cell Therapeutics Inc. (OTC:BCLI), Stem Cell Therapeutics Corp. (CVE:SSS), CRYO-CELL International, Inc. (OTC:CCEL), CellCyte Genetics Corporation (OTC:CCYG), Stem Cell Innovations Inc. (PINK:SCLL). BioMimetic Therapeutics, Inc. (NASDAQ:BMTI), Mesoblast Ltd. (ASX:MSB), Cytori Therapeutics Inc. (NASDAQ:CYTX), SANUWAVE Health, Inc. (OTC:SNWV), Stem Cell Assurance, Inc. (Pink:SCLZ), Proteonomix, Inc. (OTC:PROT), Vitro Diagnostics, Inc. (PINK:VODG), Genesis Biopharma Inc. (OTC:GNBP), Medistem Inc. (PINK:MEDS), Bioheart, Inc. (OTC:BHRT), XYTOS Inc. (PINK:XYTS), ReNeuron Group Plc. (LON:RENE), BioLife Solutions, Inc. (OTC:BLFS), Life Technologies Corp. (NASDAQ:LIFE), China Cord Blood Corp. (NYSE:CO), Talon Therapeutics Inc. (OTC:TLON), RegeneRx Biopharmaceuticals, Inc. (OTC:RGRX) Regenicin, Inc. (OTC:RGIN), RegenoCELL Therapeutics Inc. (OTC:RCLL), American CryoStem Corp. (OTC:CRYO), BIOSTEM US Corp. (PINK:BOSM), Fibrocell Science, Inc. (OTC:FCSC), Shrink Nanotechnologies, Inc. (PINK:INKN), Nuvilex Inc. (PINK:NVLX), Providential Holdings, Inc. (PINK:PHIE), Osiris Therapeutics, Inc. (NASDAQ:OSIR), InoLife Technologies Inc. (PINK:INOL), Intellicell Biosciences Inc. (PINK:SVFC), Invivo Therapeutics Holdings Corp. (OTC:NVIV), AmStem Corp. (PINK:AMST), ImmuneRegen BioSciences, Inc. (PINK:IRBS), RBC Life Sciences (PINK:RBCL), ProtoKinetix (OTC:PKTX), Tengion (NASDAQ:TNGN) and Pathfinder Cell Therapy, Inc. (PINK:SYMD).

Disclosure: Stem Cell Media, LLC., nor any of its companies was compensated for this release. Always consult an investment professional before an investment.